Aarotax Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 27-06-2024
- Paid Up Capital ₹ 0.50 M
as on 27-06-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
as on 27-06-2024
- Satisfied Charges ₹ 1.50 M
as on 27-06-2024
- Revenue 17.63%
(FY 2021)
- Profit -59.42%
(FY 2021)
- Ebitda 12.98%
(FY 2021)
- Net Worth 39.37%
(FY 2021)
- Total Assets 1.74%
(FY 2021)
About Aarotax Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹7.50 M. The company has closed loans amounting to ₹1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ajit Srivastava, Rupali Srivastava, and Shubham Srivastava serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PTC104772
- Company No.
104772
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aarotax Pharmaceuticals Private Limited offer?
Aarotax Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes, Pharma & Bioanalytical Services, PCD Pharma Franchise.
Who are the key members and board of directors at Aarotax Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupali Srivastava  | Managing Director | 03-Jul-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajit Srivastava | Director | 16-Oct-2018 | Current |
| Shubham Srivastava | Director | 14-Dec-2021 | Current |
Financial Performance of Aarotax Pharmaceuticals.
Aarotax Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 17.63% increase. The company also saw a substantial fall in profitability, with a 59.42% decrease in profit. The company's net worth Soared by an impressive increase of 39.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aarotax Pharmaceuticals?
Unlock access to Aarotax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 10 Jun 2020 | ₹7.50 M | Open |
Others Creation Date: 23 Oct 2019 | ₹1.50 M | Satisfied |
How Many Employees Work at Aarotax Pharmaceuticals?
Unlock and access historical data on people associated with Aarotax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarotax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarotax Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
